Clinical Outcome of an Multicentre, Randomized, Phase II Clinical Trial for Patients with Extranodal NK/T Cell Lymphoma Treated By P-Gemox or Aspametdex
第一作者机构:[1]Sun Yat Sen Univ, Canc Ctr, Guangzhou, Guangdong, Peoples R China
推荐引用方式(GB/T 7714):
Huang Hui-qiang,Yan Gao,Su Hang,et al.Clinical Outcome of an Multicentre, Randomized, Phase II Clinical Trial for Patients with Extranodal NK/T Cell Lymphoma Treated By P-Gemox or Aspametdex[J].BLOOD.2019,134:doi:10.1182/blood-2019-123478.
APA:
Huang, Hui-qiang,Yan, Gao,Su, Hang,Huang, Yunhong,Gao, Yuhuan...&Jiang, Wenqi.(2019).Clinical Outcome of an Multicentre, Randomized, Phase II Clinical Trial for Patients with Extranodal NK/T Cell Lymphoma Treated By P-Gemox or Aspametdex.BLOOD,134,
MLA:
Huang, Hui-qiang,et al."Clinical Outcome of an Multicentre, Randomized, Phase II Clinical Trial for Patients with Extranodal NK/T Cell Lymphoma Treated By P-Gemox or Aspametdex".BLOOD 134.(2019)